Amneal Pharmaceuticals, Inc. (AMRX)
19.33
-0.17
(-0.87%)
USD |
NASDAQ |
Sep 23, 16:00
19.40
+0.07
(+0.36%)
Pre-Market: 08:28
Amneal Pharmaceuticals Cash from Operations (TTM) : 198.80M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 198.80M |
| March 31, 2026 | 303.86M |
| December 31, 2025 | 339.99M |
| September 30, 2025 | 327.68M |
| June 30, 2025 | 351.01M |
| March 31, 2025 | 306.85M |
| December 31, 2024 | 295.03M |
| September 30, 2024 | 150.97M |
| June 30, 2024 | 90.04M |
| March 31, 2024 | 39.04M |
| December 31, 2023 | 183.16M |
| September 30, 2023 | 185.92M |
| June 30, 2023 | 198.64M |
| March 31, 2023 | 128.47M |
| December 31, 2022 | 65.10M |
| September 30, 2022 | 151.65M |
| June 30, 2022 | 140.45M |
| March 31, 2022 | 170.04M |
| December 31, 2021 | 241.82M |
| September 30, 2021 | 284.52M |
| June 30, 2021 | 246.93M |
| March 31, 2021 | 478.10M |
| December 31, 2020 | 379.00M |
| September 30, 2020 | 222.15M |
| June 30, 2020 | 317.29M |
| Date | Value |
|---|---|
| March 31, 2020 | 159.14M |
| December 31, 2019 | 1.705M |
| September 30, 2019 | 312.24M |
| June 30, 2019 | 234.46M |
| March 31, 2019 | 114.79M |
| December 31, 2018 | 250.23M |
| September 30, 2018 | 60.87M |
| June 30, 2018 | 67.23M |
| March 31, 2018 | 222.23M |
| December 31, 2017 | 234.19M |
| September 30, 2017 | 140.72M |
| June 30, 2017 | 146.22M |
| March 31, 2017 | 36.13M |
| December 31, 2016 | 74.60M |
| September 30, 2016 | 134.62M |
| June 30, 2016 | 128.29M |
| March 31, 2016 | 125.73M |
| December 31, 2015 | 71.93M |
| September 30, 2015 | 13.95M |
| June 30, 2015 | -12.19M |
| March 31, 2015 | 73.55M |
| December 31, 2014 | 32.82M |
| September 30, 2014 | 48.61M |
| June 30, 2014 | -6.075M |
| March 31, 2014 | 75.12M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Liquidia Corp. | 167.71M |
| Eli Lilly & Co. | 28.08B |
| Johnson & Johnson | 27.61B |
| Merck & Co., Inc. | 19.97B |
| Viatris, Inc. | 2.331B |